Last reviewed · How we verify
NCT06704126
Does Passive Movement Increase Glucose Uptake Into Muscle?
NA trial testing Passive movement in Glucose in 11 participants. Completed in 11 July 2025.
11 July 2025
Quick facts
| Lead sponsor | Lancaster University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 11 |
| Start date | 1 December 2024 |
| Primary completion | 11 July 2025 |
| Estimated completion | 11 July 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Passive movement
- Passive movement with blood flow restriction
Conditions studied
- Glucose — all drugs for Glucose →
- Insulin — all drugs for Insulin →
- Blood Flow Restriction Therapy — all drugs for Blood Flow Restriction Therapy →
- Blood Flow Velocity — all drugs for Blood Flow Velocity →
Sponsor
Lancaster University
Who can join
Adults 18 to 35, male only, with Glucose or Insulin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to examine the blood sugar response after a meal, and how three different movement protocols may impact the blood sugar level. Participants will visit the lab on three different occasions. Before each visit the participant will eat a meal we give them and have a cannula (a needle with a tube) put in their arm to allow blood sampling for the visit. Visit A will be the participant just having their legs moved by the machine, visit B will be the participant having their legs moved by the machine with the addition of blood pressure cuffs on their thighs, and visit C will just be the participant sitting still on the machine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06704126
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Passive movement
Trials testing the same drug.
- NCT06404268 — Facilitating Neuroplastic Changes of Acute Stroke Survivors · Phase 1, PHASE2 · recruiting
- NCT05008484 — Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury. · Phase 2, PHASE3 · completed
- NCT02359253 — Robot Aided Rehabilitation - Intervention · NA · recruiting
Other recruiting trials for Glucose
Currently open trials in the same condition.
- NCT06930976 — Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells · NA · recruiting
- NCT06755697 — Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Manage · NA · recruiting
- NCT05958368 — Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes · NA · recruiting
- NCT05353322 — Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health · NA · recruiting
Other Lancaster University trials
Trials by the same sponsor.
- NCT07410299 — The Perceived Point of Muscular Discomfort vs the Point of Failure in the Ageing Population- a Pilot Study · NA · not yet recruiting
- NCT07011407 — The FACIAL Study Pilot · not yet recruiting
- NCT06978309 — EMG Response in Forearm and Neck Muscles When Comparing Surgical Techniques. · completed
- NCT06768333 — Speed of Glucose Absorption During Exercise · NA · completed
- NCT06375577 — Speed of Glucose Absorption · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06704126 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lancaster University
- Last refreshed: 11 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06704126.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing